The VA Palo Alto Healthcare System requires a continuous supply of blood products and related services across five ordering periods, from June 1, 2026, to May 31, 2030. The requirements are categorized into 'SUPPLIES' and 'SERVICES.' Supplies include various plasma types (Cryoprecipitate Pooled, Fresh Frozen, Irradiated), different kinds of platelets (HLA matched, Leukoreduced, Pathogen reduced), and red cells (Autologous, Leuko Reduced, Leuko Reduced/Irradiated, Washed). Services encompass a wide range of treatments and testing, such as Chloroquine Treatment, Phenotyping, Genotyping, various blood screenings (CMV, antigen), special handling for autologous blood (Deglycerize, Freezing, Donor Fee), special requests, STAT charges for components and transportation, and numerous test referrals for antibody identification, enzyme panels, HLA typing, and related analyses. Each item specifies quantities and is listed as 'Priced,' with all deliveries designated as 'Destination' FOB.
The Department of Veterans Affairs (VA) is conducting a Sources Sought notice (36C26126Q0165) for Human Blood and Blood Related Products for the VA Palo Alto Health Care System (VAPAHCS). This market research aims to identify qualified sources, including various business size classifications (SDVOSB/VOSB, Hub zone, 8(a), small, disadvantaged, woman-owned, large business), capable of providing these products. The NAICS code for this effort is 621991 (Blood and Organ Banks), and the PSC is 6506 (Blood and Blood Products). Contractors must be FDA-registered, located within one hour of VAPAHCS for timely delivery, and supply 100% volunteer donor blood. The contract period includes one initial period and four option years, spanning from June 2026 to September 2030. Interested vendors are requested to submit a 2-3 page capability statement by November 24, 2025, detailing past experience, GSA schedule information, UEI number, business size, and socio-economic status. This notice is solely for market research; a solicitation may follow, and responses are not considered offers.
The Statement of Work outlines requirements for contractors to provide human blood, blood components, and related services to the VA Palo Alto Health Care System (VAPAHCS). Adherence to FDA guidelines, particularly for bacteria risk control with a preference for single-step strategies (LVDS or pathogen reduction), is mandatory. Blood must be typed for ABO and Rh antigens according to AABB standards and tested for various infectious agents including syphilis, HIV, hepatitis B and C, and HTLV. All blood must come from volunteer donors and collection procedures must be aseptic, with clear labeling and specific shelf-life guidelines for different anticoagulants. Red blood cell products must be supplied within 15 days of collection, with a return policy for exceeding this limit. The contractor must perform extensive pre-delivery testing and notify the VA of any potentially infectious blood components. Delivery schedules for STAT, ASAP, and stock orders are specified, along with conditions for returning units and procedures for reference services.